C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis

Clinical Nephrology

Volumn 76, Issue 6, 2011, Pages 425-434

  Marinelli, A ^a   Orlandi, L ^b   Stivali, G ^b  

^a Riuniti Hospital Anzio   (Italy)

^b Baxter SPA   (Italy)

Author keywords

Arterial calcification; End stage renal disease; Hemodialysis ultrasonography

Indexed keywords

ALUMINUM SALT; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM CARBONATE; CINACALCET; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARICALCITOL; SEVELAMER;

ADULT; ARTERY CALCIFICATION; ARTERY INTIMA; ARTICLE; B SCAN; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROTEIN BLOOD LEVEL;

ADULT; AGED; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; FEMALE; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYAMINES; RENAL DIALYSIS; TUNICA INTIMA; TUNICA MEDIA; VASCULAR CALCIFICATION;

EID: 84855446876     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107003     Document Type: Article

References (60)

1. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003; 18: 1731-1740
2. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2004; 19: 1489-1496.
3. Porter CJ, Stavroulopoulos A, Roe SD, Pointon K, Cassidy MJ. Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes. Nephrol Dial Transplant. 2007; 22: 3208-3213.
4. Maher JE, Raz JA, Bielak LF, Sheedy PF II, Schwartz RS, Peyser PA. Potential of quantity of coronary artery calcification to identify new risk factors for asymptomatic atherosclerosis. Am J Epidemiol. 1996; 144: 943-953.
5. Wong ND, Kouwabunpat D, Vo AN, Detrano RC, Eisenberg H, Goel M, Tobis JM. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am Heart J. 1994; 127: 422-430.
6. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol. 2004; 15: 2959-2964.
7. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002; 106: 100-105
8. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis. 2001; 38: 64-69.
9. Kobayashi S, Oka M, Maesato K, Ikee R, Mano T, Hidekazu M, Ohtake T. Coronary artery calcification, ADMA, and insulin resistance in CKD patients. Clin J Am Soc Nephrol. 2008; 3: 1289-1295.
10. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002; 39: 695-701.
11. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronaryartery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342: 1478-1483.
12. Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant. 2004; 19: 2307-2312.
13. Robinson J, Tan AU, Wilensky RL, Matthai W, Munoz M, Rosas SE. Electron-beam computerized tomography correlates with coronary angiogram in chronic kidney disease patients. Am J Nephrol. 2007; 27: 247-252.
14. Sharples EJ, Pereira D, Summers S, Cunningham J, Rubens M, Goldsmith D, Yaqoob MM. Coronary artery calcification measured with electronbeam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Am J Kidney Dis. 2004; 43: 313-319.
15. Hojs R, Hojs-Fabjan T, Balon BP. Atherosclerosis in patients with end-stage renal failure prior to initiation of hemodialysis. Ren Fail. 2003; 25: 247-254.
16. Gruberg L, Rai P, Mintz GS, Canos D, Pinnow E, Satler LF, Pichard AD, Kent KM, Waksman R, Lindsay J, Weissman NJ. Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. Am J Cardiol. 2005; 96: 892-896.
17. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002; 61: 638-647.
18. Damjanovic T, Djuric S, Schlieper G et al. Clinical features of hemodialysis patients with intimal versus medial vascular calcifications. J Nephrol. 2009; 22: 358-366.
19. Tsuchiya M, Suzuki E, Egawa K, Nishio Y, Maegawa H, Inoue S, Mitsunami K, Morikawa S, Inubushi T, Kashiwagi A. Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients. Diabetes Care. 2004; 27: 2409-2415.
20. Cozzolino M, Galassi A, Biondi ML, Turri O, Papagni S, Mongelli N, Civita L, Gallieni M, Brancaccio D. Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients. Am J Nephrol. 2006; 26: 423-429.
21. Rabbia C, De Lucchi R, Cirillo R. La patologia non aterosclerotica (U.Riba) Ecodoppler vascolare edizione 1999. p. 600-610
22. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant. 2009; 24: 948-955.
23. Sigrist M, Bungay P, Taal MW, McIntyre CW. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant. 2006; 21: 707-714.
24. Drüeke TB. Arterial intima and media calcification: distinct entities with different pathogenesis or all the same? Clin J Am Soc Nephrol. 2008; 3: 1583-1584.
25. Lehto S, Niskanen L, Suhonen M, Rönnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996; 16: 978-983.
26. Savage T, Clarke AL, Giles M, Tomson CR, Raine AE. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant. 1998; 13: 2004-2012.
27. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K. Morphology of coronary atherosclerotic lesions in patients with endstage renal failure. Nephrol Dial Transplant. 2000; 15: 218-223.
28. Gonçalves I, Lindholm MW, Pedro LM, Dias N, Fernandes e Fernandes J, Fredrikson GN, Nilsson J, Moses J, Ares MP. Elastin and calcium rather than collagen or lipid content are associated with echogenicity of human carotid plaques. Stroke. 2004; 35: 2795-2800.
29. Gross ML, Meyer HP, Ziebart H, Rieger P, Wenzel U, Amann K, Berger I, Adamczak M, Schirmacher P, Ritz E. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol. 2007; 2: 121-134.
30. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008; 117: 2938-2948.
31. Vik A, Mathiesen EB, Notø AT, Sveinbjørnsson B, Brox J, Hansen JB. Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. Atherosclerosis. 2007; 191: 128-134.
32. Mesquita M, Demulder A, Damry N, Mélot C, Wittersheim E, Willems D, Dratwa M, Bergmann P. Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clin Chem Lab Med. 2009; 47: 339-346.
33. Cozzolino M, Mazzaferro S, Pugliese F, Brancaccio D. Vascular calcification and uremia: what do we know? Am J Nephrol. 2008; 28: 339-346.
34. Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant. 2008; 23: 3263-3271.
35. Jono S, Ikari Y, Vermeer C, Dissel P, Hasegawa K, Shioi A, Taniwaki H, Kizu A, Nishizawa Y, Saito S. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Haemost. 2004; 91: 790-794.
36. Hruska KA, Mathew S, Davies MR, Lund RJ. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives. Kidney Int Suppl. 2005; 68: S142-S151.
37. Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T, Ishimura E, Nishizawa Y. Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int. 2006; 17: 1506-1513.
38. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55: 648-658.
39. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000; 35: 469-476.
40. Spiegel DM, Raggi P, Smits G, Block GA. Factors associated with mortality in patients new to haemodialysis. Nephrol Dial Transplant. 2007; 22: 3568-3572.
41. Ishimura E, Okuno S, Kitatani K, Maekawa K, Izumotani T, Yamakawa T, Jono S, Shoji T, Shioi A, Inaba M, Massry SG, Nishizawa Y. C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Semin Nephrol. 2004; 24: 408-412.
42. Wanner C, Richardson D, Fouque D, Stenvinkel P. OPTA - Influence of inflammation/infection on anaemia therapy in haemodialysis patients. Nephrol Dial Transplant. 2007; 22 (Suppl. 3): iii7-iii12.
43. Kanaan N, Goffin E, Maisin D, Struyven J, Jadoul M. CRP measurement: does the assay matter in hemodialysis patients? Clin Nephrol. 2008; 70: 503-507.
44. Niskanen L, Siitonen O, Suhonen M, Uusitupa MI. Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care. 1994; 17: 1252-1256.
45. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 1599-1605.
46. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality in patients with endstage renal disease. J Am Soc Nephrol. 2002; 13: 1894-1900.
47. Arad Y, Newstein D, Cadet F, Roth M, Guerci AD. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol. 2001; 21: 2051-2058.
48. McCullough PA. Effect of lipid modification on progression of coronary calcification. J Am Soc Nephrol. 2005; 16 (Suppl 2): S115-S119.
49. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004; 19 (Suppl 5): V59-V66.
50. Cheung AK. Is lipid control necessary in hemodialysis patients? Clin J Am Soc Nephrol. 2009; 4 (Suppl 1): S95-S101.
51. Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K. Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol. 2007; 18: 293-303.
52. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-3421
53. Kronenberg F, Mündle M, Längle M, Neyer U. Prevalence and progression of peripheral arterial calcifications in patients with ESRD. Am J Kidney Dis. 2003; 41: 140-148.
54. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G et al; AURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009; 360: 1395-1407.
55. Ferramosca E, Burke S, Chasan-Taber S, Ratti C, Chertow GM, Raggi P. Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J. 2005; 149: 820-825.
56. Caglar K, Yilmaz MI, Saglam M, Cakir E, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Vural A, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Shortterm treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol. 2008; 3: 61-68.
57. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. 1998; 339: 1972-1978.
58. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352: 20-28.
59. Qunibi WY. Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD). Kidney Int Suppl. 2005; 67 (s95): S43-S50.
60. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005; 68: 1815-1824.